Latest news
Definium Therapeutics, Inc. (NASDAQ:DFTX) Receives Average Recommendation of "Buy" from Analysts - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:43:13 GMTDefinium Therapeutics (NASDAQ:DFTX) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTDefinium Therapeutics (DFTX) Reports Strong Phase III Data, Is It Still Below Fair Value? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 21:28:36 GMTDFTX Reiterated by Piper Sandler -- Price Target Raised to $75.0 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:14:40 GMTDefinium Therapeutics (NASDAQ:DFTX) Given "Overweight" Rating at Piper Sandler - MarketBeatMarketBeat · Fri, 07 Aug 2026 17:27:23 GMTDFTX270115P00025000 interactive stock chart | DFTX Jan 2027 25.000 put stock - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 12:35:38 GMTDefinium Therapeutics (DFTX) Boosts Cash Reserves Amid Psychedelic Medicine Advances - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:29:32 GMTIs Definium Therapeutics Inc (DFTX) Facing Challenges After Repo - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:04:00 GMT